Learn how our polymer-based transfection reagents enable CRISPR activity and open new possibilities for gene editing.
Engineered for high-efficiency gene editing.
GFP Knockout
- CRISP-Fect delivers Cas9/sgRNA efficiently to the GFP locus.
- Robust loss of fluorescence highlights high editing performance.
CRISP-Fect: Functional Knockout Validated by qPCR
- Potent survivin gene disruption leads to pronounced loss of cell viability.
- qPCR confirms high-efficiency CRISPR editing.
About CRISP-Fect and Genome Editing Delivery
CRISP-Fect is a polymer-based transfection platform developed by RJH Biosciences to support efficient delivery of CRISPR components, including Cas9 mRNA, sgRNA, and ribonucleoprotein (RNP) complexes. Optimized for high editing performance, the system enables reliable genome modification across a range of in vitro applications.
By combining precise nucleic acid delivery with strong functional outcomes such as GFP knockout and survivin gene disruption, CRISP-Fect supports researchers advancing gene editing, functional genomics, and therapeutic development workflows.
To learn more about our polymer-based delivery technologies for CRISPR and mRNA applications, contact RJH Biosciences or explore our transfection platform portfolio.
